PharmiWeb Today Story
- Chris Boshoff to lead all Research and Development functions including Oncology
- Oncology Unit end-to-end structure to remain intact, reporting to Boshoff
- Roger Dansey to become Interim Chief Oncology Officer and Johanna Bendell to join Pfizer as Oncology Chief Development Officer
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff, M.D., PhD, as Chief Scientific Officer and President, Research & Development effective January 1, 2025. Dr. Boshoff, who most recently served as Chief Oncology Officer and Executive Vice President, will succeed Dr. Mikael Dolsten whose departure from Pfizer was announced earlier this year. In his new role, Dr. Boshoff will remain a member of Pfizer’s Executive Leadership Team reporting to Chairman and Chief Executive Officer, Dr. Albert Bourla, and he will oversee all functions of Research & Development across all therapeutic areas.
Pfizer’s Oncology R&D organization will maintain its fully integrated structure with Roger Dansey, M.D. serving as Interim Chief Oncology Officer, reporting to Dr. Boshoff effective January 1, 2025. Dr. Dansey will assist Dr. Boshoff in selecting a permanent Chief Oncology Officer, after which time he will retire from Pfizer. He will also facilitate a smooth transition of his current responsibilities to his successor, Johanna Bendell, M.D. who will be joining Pfizer from Roche in 2025 as Chief Development Officer, Oncology.
“Dr. Boshoff is the ideal leader to propel Pfizer’s …
Read More...Articles
How to Actually Network at an Industry Event
28-Oct-2024
How AI is Impacting Graduate Recruitment
23-Oct-2024
Trick or Treat: Spotting Red Flags in Job Offers
15-Oct-2024
Featured Events
-
6th CAR-TCR Summit
30-Aug-2021 - 02-Sep-2021 -
Next Generation Cancer Vaccine Development Summit…
07-Sep-2021 - 09-Sep-2021 -
HFpEF Drug Discovery & Development Summit 2022
25-Jan-2022 - 27-Jan-2022 -
Pharmaceutical Manufacturing and Packaging Congres…
20-Jun-2022 - 21-Jun-2022 -
Bioprocessing and the future of food
06-Jul-2022 - 07-Jul-2022 -
PM Society: Measuring Patient Engagement: Opening…
12-Oct-2022 - 12-Oct-2022
News
-
Sonoma Pharmaceuticals Announces Relaunch of Presc…
21-Nov-2024 -
Sonoma Pharmaceuticals Announces Relaunch of Presc…
21-Nov-2024 -
Modular Medical Announces Proposed Public Offering…
21-Nov-2024 -
Protagonist Announces Nomination of PN-881, a Pote…
21-Nov-2024 -
Arlington Medical Waste Disposal Company Addresses…
21-Nov-2024 -
1upHealth Ranked Number 43 Fastest-Growing Company…
21-Nov-2024